Brazilian diet pills may be harmful, warns US FDA

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2006年 / 1085卷 / 1期

关键词：

Public Health; Adverse Effect; Positive Result; Drug Interaction; Fluoxetine;

D O I：

10.2165/00128415-200610850-00004

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[21] FDA warns antiepileptic drugs may increase risk of suicide
Ralat, Jose
[J]. CNS SPECTRUMS, 2008, 13 (03) : 191 - 191
[22] Propylthiouracil may cause serious liver injury, warns FDA
[J]. Reactions Weekly, 2009, 1256 (1) : 2 - 2
[23] US FDA Commissioner warns of "devastating" impact of funding cuts
不详
[J]. FUTURE MEDICINAL CHEMISTRY, 2011, 3 (06) : 644 - 644
[24] US FDA warns that stopping Gilenya can worsen MS
[J]. Reactions Weekly, 2018, 1730 (1) : 5 - 5
[25] US FDA warns of serious risks with psoriasis drug Raptiva®
不详
[J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (04) : 393 - 394
[26] US FDA warns of serious risks with psoriasis drug Raptiva®
不详
[J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2009, 5 (03) : 229 - 229
[27] US FDA warns of injection-site reactions with naltrexone
[J]. Reactions Weekly, 2008, 1216 (1) : 5 - 5
[28] FDA warns propylhexedrine abuse or misuse may cause serious AEs
[J]. Reactions Weekly, 2021, 1849 (1) : 9 - 9
[29] FDA warns that two lots of Tydemy may have lower efficacy
[J]. Reactions Weekly, 2023, 1969 (1) : 3 - 3
[30] Protease inhibitors may raise blood glucose levels, FDA warns
不详
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (14) : 1575 - 1575

← 1 2 3 4 5 →